BI-44847

• Description:

  BI-44847 is a selective and orally active SGLT2 inhibitor. BI-44847 can increase UGE and decrease HbA1c levels. BI-44847 shows improvement in fasting and fed glucose levels. BI-44847 can be studied in research on type 2 diabetes mellitus (T2DM) [1].

• UNSPSC:

  12352005

• Target:

  SGLT

• Related Pathways:

  Membrane Transporter/Ion Channel

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Metabolic Disease

• Smiles:

  O[C@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)[C@H]1OC2=NN(C(C)C)C(C)=C2CC3=CC=C(OC)C=C3F

• Molecular Formula:

  C21H29FN2O7

• Molecular Weight:

  440.46

• References & Citations:

  [1]Malla, P., et al. (2014) . Ramping glucosuria for management of type 2 diabetes mellitus: an emerging cynosure. Medicinal research reviews, 34 (6), 1146-1167.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  Phase 1

• CAS Number:

  [421592-30-5]